APA (7th ed.) Citation

H, W., U, E., F, R., D, T., H, B., B, R., & K, D. (2012). Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone. Clinical drug investigation, 32(10), 673. https://doi.org/10.2165/11635280-000000000-00000

Chicago Style (17th ed.) Citation

H, Wiesinger, Eydeler U, Richard F, Trummer D, Blode H, Rohde B, and Diefenbach K. "Bioequivalence Evaluation of a Folate-supplemented Oral Contraceptive Containing Ethinylestradiol/drospirenone/levomefolate Calcium Versus Ethinylestradiol/drospirenone and Levomefolate Calcium Alone." Clinical Drug Investigation 32, no. 10 (2012): 673. https://doi.org/10.2165/11635280-000000000-00000.

MLA (9th ed.) Citation

H, Wiesinger, et al. "Bioequivalence Evaluation of a Folate-supplemented Oral Contraceptive Containing Ethinylestradiol/drospirenone/levomefolate Calcium Versus Ethinylestradiol/drospirenone and Levomefolate Calcium Alone." Clinical Drug Investigation, vol. 32, no. 10, 2012, p. 673, https://doi.org/10.2165/11635280-000000000-00000.